Role of mouse and human CYP2A enzymes in the bioactivation of the tobacco-specific lung procarcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)

被引：0
|
作者：
Ding, Xinxin [1 ]
Zhou, Xin [1 ]
机构：
[1] NYSDOH, Wadsworth Ctr, Albany, NY USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-3236
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3236
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Molecular modelling of CYP2A enzymes: application to metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Jalas, JR
    Seetharaman, M
    Hecht, SS
    Murphy, SE
    XENOBIOTICA, 2004, 34 (06) : 515 - 533
  • [2] Recent studies on mechanisms of bioactivation and detoxification of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK), a tobacco-specific lung carcinogen
    Hecht, SS
    CRITICAL REVIEWS IN TOXICOLOGY, 1996, 26 (02) : 163 - 181
  • [3] Carbonyl reduction of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in cytosol of mouse liver and lung
    Atalla, A
    Maser, E
    TOXICOLOGY, 1999, 139 (1-2) : 155 - 166
  • [4] Biotransformation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in freshly isolated human lung cells
    Smith, GBJ
    Castonguay, A
    Donnelly, PJ
    Reid, KR
    Petsikas, D
    Massey, TE
    CARCINOGENESIS, 1999, 20 (09) : 1809 - 1818
  • [5] Metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in the urine of newborns.
    Hecht, SS
    Carmella, SG
    Chen, ML
    Salzberger, U
    Tollner, U
    Lackmann, GM
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1998, 216 : U555 - U555
  • [6] Role of CYP2A13 in the bioactivation and lung tumorigenicity of the tobacco-specific lung procarcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone: in vivo studies using a CYP2A13-humanized mouse model
    Megaraj, Vandana
    Zhou, Xin
    Xie, Fang
    Liu, Zhihua
    Yang, Weizhu
    Ding, Xinxin
    CARCINOGENESIS, 2014, 35 (01) : 131 - 137
  • [7] Genetic variability in the metabolism of the tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) to 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL)
    Ter-Minassian, Monica
    Asomaning, Kofi
    Zhao, Yang
    Chen, Feng
    Su, Li
    Carmella, Steven G.
    Lin, Xihong
    Hecht, Stephen S.
    Christiani, David C.
    INTERNATIONAL JOURNAL OF CANCER, 2012, 130 (06) : 1338 - 1346
  • [8] Kava Effects on the Metabolism of Tobacco-Specific Carcinogen 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone (NNK) in Humans
    Oostra, Drew
    Fujioka, Naomi
    Xing, Chengguo
    Narayanapillai, Sreekanth
    Paladino, Jordan
    Alves, Hannah
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S455 - S455
  • [9] Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Muscat, JE
    Djordjevic, MV
    Colosimo, S
    Stellman, SD
    Richie, JP
    CANCER, 2005, 103 (07) : 1420 - 1426
  • [10] Characterization of human lung enzymes involved in the reduction of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)
    Ashmore, Joseph
    Liu, Ying
    Peterson, Amity
    Fechtner, Sabrina
    Chen, Gang
    Lazarus, Philip
    CANCER RESEARCH, 2015, 75
12345